948 related articles for article (PubMed ID: 17586478)
1. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
[TBL] [Abstract][Full Text] [Related]
3. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
[TBL] [Abstract][Full Text] [Related]
4. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
5. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
6. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.
Van Uden E; Kang DE; Koo EH; Masliah E
Microsc Res Tech; 2000 Aug; 50(4):268-72. PubMed ID: 10936878
[TBL] [Abstract][Full Text] [Related]
7. Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex.
Kim HS; Lee SH; Kim SS; Kim YK; Jeong SJ; Ma J; Han DH; Cho BK; Suh YH
Neuroreport; 1998 Feb; 9(3):533-7. PubMed ID: 9512402
[TBL] [Abstract][Full Text] [Related]
8. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.
Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL
Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100
[TBL] [Abstract][Full Text] [Related]
10. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
11. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein expression in the rat hippocampal dentate gyrus modulates during memory consolidation.
Conboy L; Murphy KJ; Regan CM
J Neurochem; 2005 Dec; 95(6):1677-88. PubMed ID: 16236032
[TBL] [Abstract][Full Text] [Related]
13. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
Nawrot B
Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
[TBL] [Abstract][Full Text] [Related]
14. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
15. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H; Shen Y
Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
[TBL] [Abstract][Full Text] [Related]
16. APP gene family: unique age-associated changes in splicing of Alzheimer's betaA4-amyloid protein precursor.
Sandbrink R; Masters CL; Beyreuther K
Neurobiol Dis; 1994 Nov; 1(1-2):13-24. PubMed ID: 9216982
[TBL] [Abstract][Full Text] [Related]
17. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
18. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
19. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
Tanahashi H; Tabira T
Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
[TBL] [Abstract][Full Text] [Related]
20. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]